Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: Possible involvement in intracardiac thrombogenesis

Thrombosis Research

Volumn 111, Issue 3, 2003, Pages 137-142

  Nakamura, Yoichi ^a   Nakamura, Kazufumi ^b   Fukushima Kusano, Kengo ^b   Ohta, Keiko ^b   Matsubara, Hiromi ^b   Hamuro, Tsutomu ^c   Yutani, Chikao ^d   Ohe, Tohru ^b  

^a MATSUYAMA SHIMIN HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c Chemo Sero Therapeut Res Institute   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Embolism; Myocarditis; Thrombogenesis; von Willebrand factor

Indexed keywords

THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCARDIUM; ENDOTHELIUM INJURY; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCOAGULABILITY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTRACARDIAC THROMBOSIS; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THROMBOGENESIS; TISSUE DISTRIBUTION;

EID: 0348110434     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00405-5     Document Type: Article

References (37)

1. Black I.W., Hopkins A.P., Lee L.C., Walsh W.F. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am. Heart J. 126:1993;375-381.
2. Archer S.L., James K.E., Kvernen L.R., Cohen I.S., Ezekowitz M.D., Gornick C.C. Role of transesophageal echocardiography in the detection of left atrial thrombus in patients with chronic nonrheumatic atrial fibrillation. Am. Heart J. 130:1995;287-295.
3. Petersen P., Boysen G., Godtfredsen J., Andersen E.D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. i:1989;175-179.
4. Stroke Prevention in Atrial Fibrillation Investigators Stroke prevention in atrial fibrillation study. Circulation. 84:1991;527-539.
5. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N. Engl. J. Med. 323:1990;1505-1511.
6. Connolly S.J.et al. Canadian atrial fibrillation anticoagulation (CAFA) study. J. Am. Coll. Cardiol. 18:1991;349-355.
7. Ezekowitz M.D.et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N. Engl. J. Med. 327:1992;1406-1412.
8. Santiago D., Warshofsky M., Li Mandri G., Di Tuullio M., Coromilas J., Reiffel J.et al. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. J. Am. Coll. Cardiol. 24:1994;159-164.
9. Shively B.K., Gelgand E.A., Crawford M.H. Regional left atrial stasis during atrial fibrillation and flutter: determinants and relation to stroke. J. Am. Coll. Cardiol. 27:1996;1722-1729.
10. Heppell R.M., Berkin K.E., McLenachan J.M., Devies J.A. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart. 77:1997;407-411.
11. Sohara H., Amitani S., Kurose M., Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J. Am. Coll. Cardiol. 29:1997;106-112.
12. Li-Saw-Hee F.L., Blann A.D., Lip G.Y. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. J. Am. Coll. Cardiol. 35:2000;1926-1931.
13. Topcuoglu M.A., Haydari D., Ozturk S., Ozcebe O.I., Saribas O. Plasma levels of coagulation and fibrinolysis markers in acute ischemic stroke patients with lone atrial fibrillation. Neurol. Sci. 21:2000;235-240.
14. Giansante C., Fiotti N., Miccio M., Altamura N., Salvi R., Guarnieri G. Coagulation indicators in patients with paroxysmal atrial fibrillation: effects of electric and pharmacologic cardioversion. Am. Heart J. 140:2000;423-429.
15. Mondillo S., Sabatini L., Agricola E., Ammaturo T., Guerrini F., Barbati R.et al. Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation. Int. J. Cardiol. 75:2000;227-232.
16. Chung N.A., Belgore F., Li-Saw-Hee F.L., Conway D.S., Blann A.D., Lip G.Y. Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor? Stroke. 33:2002;2187-2191.
17. Sagripanti A., Carpi A. Antithrombotic and prothrombotic activities of the vascular endothelium. Biomed. Pharmacother. 54:2000;107-111.
18. Aretz H.T., Billingham M.E., Edwards W.D., Factor S.M., Fallon J.T., Fenoglio J.J. Jret al. Myocarditis. A histopathologic definition and classification. Am. J. Cardiovasc. Pathol. 1:1987;3-14.
19. Semeraro N., Colucci M. Tissue factor in health and disease. Thromb. Haemost. 78:1997;759-764.
20. Hatakeyama K., Asada Y., Marutsuka K., Sato Y., Kamikubo Y., Sumiyoshi A. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis. 133:1997;213-219.
21. Caplice N.M., Mueske C.S., Kleppe L.S., Simari R.D. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity. Circulation. 98:1998;1051-1057.
22. Shimura M., Wada H., Wakita Y., Nakase T., Hiyoyama K., Nagaya S.et al. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation. Am. J. Hematol. 52:1996;165-170.
23. Soejima H., Ogawa H., Yasue H., Kaikita K., Nishiyama K., Misumi K.et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation. 99:1999;2908-2913.
24. He M., Wen Z., He X., Xiong S., Liu F., Xu J.et al. Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases. Thromb. Res. 107:2002;223-228.
25. Gando S., Kameue T., Matusda N., Hyakawa M., Morimoto Y., Ishitani T.et al. Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. Thromb. Res. 109:2003;119-124.
26. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 96:1997;1180-1184.
27. Suttorp M.J., Kingma J.H., Koomen E.M., van 't Hof A., Tijssen J.G., Lie K.I. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am. J. Cardiol. 71:1993;710-713.
28. Armstrong D.S., Menahem S. Cardiac arrhythmias as a manifestation of acquired heart disease in association with paediatric respiratory syncytial virus infection. J. Paediatr. Child Health. 29:1993;309-311.
29. Donnerstein R.L., Berg R.A., Shehab Z., Ovadia M. Complex atrial tachycardias and respiratory syncytial virus infections in infants. J. Pediatr. 125:1994;23-28.
30. Frustaci A., Cameli S., Zeppilli P. Biopsy evidence of atrial myocarditis in an athlete developing transient sinoatrial disease. Chest. 108:1995;1460-1462.
31. Shah S.S., Hellenbrand W.E., Gallagher P.G. Atrial flutter complicating neonatal Coxsackie B2 myocarditis. Pediatr. Cardiol. 19:1998;185-186.
32. Kishimoto C., Ochiai H., Sasayama S. Intracardiac thrombus in murine Coxsackie virus B3 myocarditis. Heart Vessels. 7:1992;76-81.
33. Edgington T.S., Mackman N., Brand K., Ruf W. The structural biology of expression and function of tissue factor. Thromb. Haemost. 66:1991;67-79.
34. Monaco C., Andreakos E., Young S., Feldmann M., Paleolog E. T cell-mediated signaling to vascular endothelium: induction of cytokines, chemokines, and tissue factor. J. Leukoc. Biol. 71:2002;659-668.
35. Xuereb J.M., Sie P., Boneu B., Constans J. Up-regulation of tissue factor expression by platelet-derived growth factor in human vascular smooth muscle cells in culture. Thromb. Haemost. 78:1997;1520-1526.
36. Carmeliet P., Collen D. Tissue factor. Int. J. Biochem. Cell Biol. 30:1998;661-667.
37. Goldsmith I., Kumar P., Carter P., Blann A.D., Patel R.I., Lip G.Y. Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study. Am. Heart J. 140:2000;777-784.